Menu

Experience

Jonie Kondracki

    • 89bio – $98 Million IPO 


    • Phathom Pharmaceuticals - $209 Million IPO 


    • IGM Biosciences – $201 Million IPO  


    • CrowdStrike $704 Million IPO 


    • Harpoon Therapeutics - $76 Million IPO 


    • Advaxis – $30 Million Registered Direct Offering 


    • Gemphire Therapeutics – $30 Million IPO 


    • Inotek Pharmaceuticals – $50 Million Follow-On 


    • Ooma Prices $65 Million IPO 


    • Ascendis Pharma closes $124 million IPO 


    • New Relic Completes $132 Million Initial Public Offering 


    • New Relic Completes $132 Million Initial Public Offering  


    • Xenon Pharmaceuticals Completes Initial Public Offering 


    • Zendesk's $115 Million Initial Public Offering 


    • TriVascular Initial Public Offering 


    • Aerohive Networks $75 Million IPO 


    • Castlight Health's $204 Million IPO 


    • LinkedIn's $1.25 Billion Follow-On Offering 


Contact us

Back to top

© 2020 Cooley LLP and Cooley (UK) LLP. All rights reserved.

Cooley® is a registered service mark of Cooley LLP in the United States and European Union as well as certain other jurisdictions.